Mirati Therapeutics, Inc.

Rafferty Asset Management, LLC

Report date

12/31/2023

Quarter

2023 Q4

Filed

2/13/2024

Shares

158,931

Value ($000)

9,337

Weight

0.0%

2019 Q4 - 2023 Q4 (17 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q4	2/13/2024	9,337	0.0%	158,931	12/31/2023
2023 Q3	11/13/2023	10,873	0.1%	249,612	9/30/2023
2023 Q2	8/11/2023	7,899	0.0%	218,639	6/30/2023
2023 Q1	5/11/2023	6,451	0.0%	173,516	3/31/2023
2022 Q4	2/13/2023	8,748	0.1%	193,073	12/31/2022
2022 Q3	11/14/2022	5,707	0.1%	81,712	9/30/2022
2022 Q2	8/12/2022	4,341	0.0%	64,664	6/30/2022
2022 Q1	5/13/2022	5,443	0.0%	66,201	3/31/2022
2021 Q4	2/10/2022	5,740	0.0%	39,131	12/31/2021
2021 Q3	11/10/2021	3,329	0.0%	18,819	9/30/2021
2021 Q2	8/10/2021	2,449	0.0%	15,161	6/30/2021
2021 Q1	5/10/2021	3,004	0.0%	17,535	3/31/2021
2020 Q4	2/10/2021	859	0.0%	3,912	12/31/2020
2020 Q3	11/13/2020	2,494	0.0%	15,021	9/30/2020
2020 Q2	8/7/2020	1,064	0.0%	9,321	6/30/2020
2020 Q1	5/15/2020	316	0.0%	4,114	3/31/2020
2019 Q4	2/10/2020	4,504	0.1%	34,951	12/31/2019